Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 3/20 | 0.40 |
| ▸ | F3 | P13726 | 3/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | ECE1 | P42892 | 1/20 | 0.40 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.40 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.40 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | BID | P55957 | 3/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9560223 | 0.98 | LIPG (0.51) | LIPGTHRATHRBF7F3 | |
| SCHEMBL9560225 | 0.98 | LIPG (0.51) | LIPGTHRATHRBF7F3 | |
| SCHEMBL12634528 | 0.95 | CYP3A4 (0.43) | LIPGTHRATHRBALOX5PTGS2 | |
| SCHEMBL29963724 | 0.88 | PTPN1 (0.39) | LIPGCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL20424338 | 0.88 | PTPN1 (0.39) | LIPGCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2447719 | 0.85 | LIPG (0.50) | LIPGTHRATHRBF7F3 | |
| SCHEMBL27531219 | 0.85 | LIPG (0.46) | LIPGTHRATHRBALOX5PTGS2 | |
| SCHEMBL27876083 | 0.85 | F7 (0.47) | LIPGTHRATHRBF7F3 | |
| SCHEMBL23406261 | 0.84 | LIPG (0.44) | LIPGTHRATHRBALOX5PTGS2 | |
| SCHEMBL9801998 | 0.83 | LIPG (0.49) | LIPGTHRATHRBF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4037642-B1 | NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR PROTECTION AGAINST BLUE LIGHT | BEIERSDORF AG (DE) | 2024-11-06 | — | — | EP | claimed |
| EP-4037639-B1 | BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM BLUE LIGHT | BEIERSDORF AG (DE) | 2024-11-06 | — | — | EP | claimed |
| EP-4037642-A1 | NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR PROTECTION AGAINST BLUE LIGHT | Beiersdorf AG (DE) | 2022-08-10 | — | — | EP | claimed |
| EP-4037639-A1 | BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM BLUE LIGHT | Beiersdorf AG (DE) | 2022-08-10 | — | — | EP | claimed |
| EP-3093004-B2 | SUN PROTECTANT FREE OF OCTOCRYLENE WITH MINIMAL STICKYNESS | BEIERSDORF AG (DE) | 2022-06-01 | — | — | EP | claimed |
| EP-3761946-B1 | FRUIT ACID-CONTAINING COSMETIC GEL | BEIERSDORF AG (DE) | 2022-03-30 | — | — | EP | claimed |
| EP-2276452-B2 | PERFUMED COSMETIC PREPARATION CONTAINING CITRONELLOL | BEIERSDORF AG (DE) | 2022-01-05 | — | — | EP | claimed |
| EP-2276449-B2 | PERFUMED COSMETIC PREPARATION | BEIERSDORF AG (DE) | 2021-12-29 | — | — | EP | claimed |
| WO-2021219622-A1 | HAND SANITISER COMPOSITION | DSM IP ASSETS B.V. (NL) | 2021-11-04 | — | — | WO | claimed |
| EP-3860553-A1 | FATTY ALCOHOL-CONTAINING, ETHANOLIC SUNSCREEN WITH A REDUCED TENDENCY TO STAIN TEXTILES | Beiersdorf AG (DE) | 2021-08-11 | — | — | EP | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-2986136-A1 | COMPOSITION AND METHOD FOR PREVENTING, REDUCING, ALLEVIATING, OR TREATING IDIOPATHIC VOMITING | The Iams Company (US) | 2016-02-24 | — | — | EP | claimed |
| WO-2015165709-A1 | CONSUMABLE FOR AN AEROSOL-GENERATING DEVICE | PHILIP MORRIS PRODUCTS S.A. (CH) | 2015-11-05 | — | — | WO | claimed |
| US-20150209259-A1 | OCTOCRYLENE-FREE SUNSCREEN COMPOSITION WITH LOW STICKINESS | BEIERSDORF AG (DE) | 2015-07-30 | — | — | US | claimed |
| EP-1666021-B1 | Personal care compositions with improved hyposensitivity | PROCTER & GAMBLE (US) | 2015-07-01 | — | — | EP | claimed |
| WO-2014143539-A1 | COMPOSITION AND METHOD FOR PREVENTING, REDUCING, ALLEVIATING, OR TREATING IDIOPATHIC VOMITING | THE IAMS COMPANY (US) | 2014-09-18 | — | — | WO | claimed |
| EP-2276451-B1 | PREPARATION FOR DAY CARE | BEIERSDORF AG (DE) | 2014-06-04 | — | — | EP | claimed |
| US-20100247476-A1 | Copolymer Containing Water-Soluble Lipids | Societe d'Exploitation de Products Pour Les Industries Chimiques SEPPIC (FR) | 2010-09-30 | — | — | US | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247476-A1 | Copolymer Containing Water-Soluble Lipids | LIPA, PHOSPHO1, ABHD16A | LIPG 43/4885THRA 2295/4885THRB 3555/4885 |
| US-20150209259-A1 | OCTOCRYLENE-FREE SUNSCREEN COMPOSITION WITH LOW STICKINESS | CUTA, TYR, TTI2 | LIPG 2911/4885THRA 459/4885THRB 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.